BL Pharmtech Corp.

KOSDAQ:A065170 Stock Report

Market Cap: ₩38.4b

BL Pharmtech Past Earnings Performance

Past criteria checks 0/6

BL Pharmtech's earnings have been declining at an average annual rate of -7.2%, while the Personal Products industry saw earnings growing at 9.9% annually. Revenues have been declining at an average rate of 23.5% per year.

Key information

-7.2%

Earnings growth rate

-1.3%

EPS growth rate

Personal Products Industry Growth3.8%
Revenue growth rate-23.5%
Return on equity-33.7%
Net Margin-62.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

BL Pharmtech (KOSDAQ:065170) Has Debt But No Earnings; Should You Worry?

Sep 03
BL Pharmtech (KOSDAQ:065170) Has Debt But No Earnings; Should You Worry?

Some Confidence Is Lacking In BL Pharmtech Corp.'s (KOSDAQ:065170) P/S

May 21
Some Confidence Is Lacking In BL Pharmtech Corp.'s (KOSDAQ:065170) P/S

Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?

Mar 07
Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?

Reflecting on Next Bt's (KOSDAQ:065170) Share Price Returns Over The Last Three Years

Mar 14
Reflecting on Next Bt's (KOSDAQ:065170) Share Price Returns Over The Last Three Years

Does Next Bt (KOSDAQ:065170) Have A Healthy Balance Sheet?

Jan 20
Does Next Bt (KOSDAQ:065170) Have A Healthy Balance Sheet?

Next Bt's (KOSDAQ:065170) Shareholders Are Down 43% On Their Shares

Nov 28
Next Bt's (KOSDAQ:065170) Shareholders Are Down 43% On Their Shares

Revenue & Expenses Breakdown

How BL Pharmtech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A065170 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2416,710-10,37715,1560
31 Mar 2420,638-15,66818,5600
31 Dec 2324,525-14,10120,1370
30 Sep 233,921-16,71618,2960
30 Jun 23-2,525-15,11117,0370
31 Mar 2310,225-14,00616,8680
31 Dec 2222,523-14,69017,1660
30 Sep 2286,983-12,23222,4190
30 Jun 2282,282-12,74123,7040
31 Mar 2283,757-20,52424,1620
31 Dec 2184,440-20,21124,1790
30 Sep 2182,378-26,47322,8980
30 Jun 2177,279-33,18221,9240
31 Mar 2169,925-20,87421,0810
31 Dec 2065,691-17,94721,9690
30 Sep 2055,847-13,48827,9870
30 Jun 2054,165-3,72027,9920
31 Mar 2053,804-9,55028,8240
31 Dec 1958,869-11,82030,1320
30 Sep 1969,732-3,64826,2880
30 Jun 1980,466-5,81830,2950
31 Mar 1989,0621,24532,5740
31 Dec 1887,6861,30231,8880
30 Sep 1884,840-1,92134,0860
30 Jun 1882,673-1,12031,2370
31 Mar 1877,494-2,45828,1410
31 Dec 1783,708-3,05626,5940
30 Sep 1779,549-2,71722,3650
30 Jun 1777,111-3,30721,6630
31 Mar 1783,728-5,31724,8070
31 Dec 1673,963-5,07624,7000
30 Sep 1670,910-8,43924,5270
30 Jun 1667,218-8,73824,3340
31 Mar 1658,819-6,25921,1680
31 Dec 1557,145-6,51420,9480
30 Sep 1556,025-1,88120,0980
30 Jun 1559,532-1,42623,1290
31 Mar 1562,883-1,30625,4940
31 Dec 1461,595-1,04325,6370
30 Sep 1460,724-1,38525,7500
30 Jun 1456,481-1,27522,1050
31 Mar 1452,124-1,20320,6660
31 Dec 1350,703-1,60819,3390
30 Sep 1345,867-2,81320,4930

Quality Earnings: A065170 is currently unprofitable.

Growing Profit Margin: A065170 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A065170 is unprofitable, and losses have increased over the past 5 years at a rate of 7.2% per year.

Accelerating Growth: Unable to compare A065170's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A065170 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (30.2%).


Return on Equity

High ROE: A065170 has a negative Return on Equity (-33.66%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies